Exparel 133 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FEQDT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,522
Award facts
- Contract value 100% obligated
- $4,521.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,521.66 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 17, 2025, for the supply of Exparel (liposomal bupivacaine) 133 mg/10 ml vials. This contract is not set-aside and is scheduled for completion by October 8, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. This delivery order represents a specific product requisition issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which is valued at approximately $500 million and extends through November 2026.
Exparel is a long-acting local anesthetic commonly used in surgical and medical applications to provide extended pain relief. DMS Pharmaceutical Group maintains a robust portfolio of pharmaceutical supply contracts with the Defense Logistics Agency, consistently delivering a comprehensive range of branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. The company's established position as a critical supplier within the federal pharmaceutical supply chain enables the Defense Logistics Agency to efficiently fulfill medical supply needs across Department of Defense healthcare sites through firm fixed-price delivery orders for specified pharmaceutical products.
Quick answers
Who was awarded contract SPE2DB25FEQDT?
SPE2DB25FEQDT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FEQDT worth?
The government has obligated $4,522 on SPE2DB25FEQDT.
Is contract SPE2DB25FEQDT an order under another contract?
Yes. SPE2DB25FEQDT is a delivery order under SPE2DB24D9113, an indefinite delivery contract.
Was contract SPE2DB25FEQDT competed?
The extent of competition for SPE2DB25FEQDT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award